Skip to content

   Pharma Publications

Neuropsychopharmacology
  • To lump or to split: cognitive impairment across mood and psychotic disorders
    Published on 2023-11-27
    2 years ago
  • Correction: Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice
    Published on 2023-11-27
    2 years ago
  • Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation
    Published on 2023-11-24
    2 years ago
  • The role of endogenous opioids in mindfulness and sham mindfulness-meditation for the direct alleviation of evoked chronic low back pain: a randomized clinical trial
    Published on 2023-11-19
    2 years ago
  • Should we embrace the term ‘preaddiction’?
    Published on 2023-11-14
    2 years ago
  • The effects of experience of discrimination and acculturation during pregnancy on the developing offspring brain
    Published on 2023-11-14
    2 years ago
  • IN MEMORIAM: John A. Sweeney, Ph.D.
    Published on 2023-11-06
    2 years ago
« Previous 1 … 57 58 59 60 61 … 143 Next »
Journal of Psychopharmacology
  • The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms
    Published on 2022-04-09
    3 years ago
  • Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms
    Published on 2022-04-07
    3 years ago
  • Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
    Published on 2022-04-07
    3 years ago
  • Clozapine and the aryl hydrocarbon receptor
    Published on 2022-04-01
    3 years ago
  • The effect of metformin on cognitive function: A systematic review and meta-analysis
    Published on 2022-03-17
    3 years ago
  • Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning
    Published on 2022-03-04
    3 years ago
  • Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ)
    Published on 2022-03-02
    3 years ago
« Previous 1 … 57 58 59 60 61 … 124 Next »
European Neuropsychopharmacology
  • Ethical considerations for precision psychiatry: A roadmap for research and clinical practice
    Published on 2022-08-29
    3 years ago
  • Gender-related association among childhood maltreatment, brain structure and clinical features in bipolar disorder
    Published on 2022-08-29
    3 years ago
  • Barriers to managing bipolar I disorder with long-acting injectable antipsychotics
    Published on 2022-08-28
    3 years ago
  • What can lifestyle factors tell us about cognitive dysfunction in bipolar disorder?
    Published on 2022-08-28
    3 years ago
  • Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders
    Published on 2022-07-30
    3 years ago
  • Polygenic risk scores for antisocial behavior in relation to amygdala morphology across an attention deficit hyperactivity disorder case-control sample with and without disruptive behavior
    Published on 2022-07-30
    3 years ago
  • Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)
    Published on 2022-07-29
    3 years ago
« Previous 1 … 57 58 59 60 61 … 145 Next »

   Pharma Pub